Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Cytotherapy|May 31, 2024
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumorsAnne Miller, Rachel Daum, Tao Wang, et al.
Nature Neuroscience|February 7, 2017
Identification of diverse astrocyte populations and their malignant analogsChia-Ching John Lin, Kwanha Yu, Asante Hatcher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 14, 2013
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastomaMeenakshi Hegde, Amanda Corder, Kevin K H Chow, et al.
Pediatric Blood & Cancer|January 20, 2025
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid TumorsAaron B Ross, Kriti Puri, Thomas L Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Nature Cancer|May 15, 2024
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profilingAli Rezvan, Gabrielle Romain, Mohsen Fathi, et al.
The Journal of Clinical Investigation|July 19, 2016
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escapeMeenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Cancer Immunology Research|August 1, 2025
Endoglin-directed CAR-T cells Comprehensively Target Tumors in Advanced SarcomasHarrison R Berger, Malina Maharana, Jeneffer Mirabal, et al.
Vaccines|August 29, 2024
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean RegionManuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Pageof 12